- Supported exchanges /
- SHE /
- 002550.SHE
Changzhou Qianhong Biopharma Co Ltd (002550 SHE) stock market data APIs
Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers its products in the form of tablets, hard capsules, lyophilized powder and lyophilized powder injections, small-volume injections, and raw materials. It provides enzymes, including pancreatic kininogenase series, asparaginase series, and compound digestive enzyme capsule II; and polysaccharides products, such as nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium. The company also offers nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium injections. In addition, it exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.
Changzhou Qianhong Biopharma Co Ltd Financial Data Overview
6.09 | |
6.39 | |
- | |
6.4 | |
6.07 | |
4.1124-7.18 | |
8 319 M | |
28.2609 | |
1 280 M | |
1 556 M | |
0.1015 | |
0.0181 | |
0.112 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Changzhou Qianhong Biopharma Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 556 M
- EBITDA 379 M
- Earnings Per Share 0.23
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Changzhou Qianhong Biopharma Co Ltd Earnings via APIs
- Latest Release 2024-10-17
- EPS/Forecast NaN
Get Changzhou Qianhong Biopharma Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: